Saccharomyces cerevisiae fungemia due to an unexpected source in the pediatric intensive care unit

Creative Commons License

GÜN E., ÖZDEMİR H., Celik D. B., BOTAN E., KENDİRLİ T.

TURKISH JOURNAL OF PEDIATRICS, cilt.64, sa.1, ss.138-141, 2022 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 64 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.24953/turkjped.2020.1668
  • Dergi Adı: TURKISH JOURNAL OF PEDIATRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.138-141
  • Anahtar Kelimeler: Saccharomyces cerevisiae, sepsis, pediatric intensive care, probiotic, fungemia, PROBIOTIC TREATMENT, INFECTION, PATIENT
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Background. Saccharomyces cerevisiae is one of the microorganisms commonly used as a probiotic. Although it is primarily known as non-pathogenic, it may cause fungemia, particularly in immunocompromised patients or children with a history of long-term hospital stay.